Closure of Peritoneum at Cesarean Section and Postoperative Adhesion
NCT ID: NCT01183000
Last Updated: 2019-07-12
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
533 participants
INTERVENTIONAL
2010-01-16
2010-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Study design: A prospective randomized trial of 533 women undergoing primary Cesarean section; 256 were randomized to non closure and 277 to closure of the peritoneum. At a subsequent cesarean,he presence of adhesions and their severity was evaluated at several sites: between the layers of the abdominal wall, between the bladder and the abdominal wall, between bladder and uterus, between the uterus and the abdominal wall, and between the bowels and the pelvic organs. A cumulative adhesion score was calculated.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Trial Comparing Barbed and Non-barbed Suture for Uterine Incision Closure at Cesarean Section
NCT02962011
Closure vs Non Closure of Rectus Muscle at Cesarean Section 5 Year Study
NCT04548570
Closing Uterine Incision During C-section Using Barbed Suture (Stratafix) or Vicryl Suture.
NCT03159871
Seprafilm® for Prevention of Adhesions at Repeat Cesarean
NCT00697606
Short Term Comparison of Two Different Techniques of Uterine Cesarean Incision Closure
NCT01287611
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
peritoneal closure
Closure of the peritoneum at cs
Injection of 5 mg Marcaine (anesthetic solution) to the leg
Non closure of the peritoneum
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Closure of the peritoneum at cs
Injection of 5 mg Marcaine (anesthetic solution) to the leg
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Previous pelvic or abdominal surgery
18 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Barzilai Medical Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
ofer gemer
Prof. Ofer Gemer
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ofer Gemer, MD
Role: PRINCIPAL_INVESTIGATOR
Barzili Medical Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Barzilai Medical Center
Ashkelon, , Israel
Barzilay University Medical Center
Ashkelon, , Israel
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
1789
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.